Surjyadipta Bhattacharjee Selected Research

NF-kappa B (NF-kB)

8/2014	Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.
12/2010	Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Surjyadipta Bhattacharjee Research Topics

Disease

14	Alzheimer Disease (Alzheimer's Disease) 08/2015 - 12/2010
2	Pain (Aches) 01/2024 - 05/2023
2	Nervous System Diseases (Neurological Disorders) 01/2012 - 12/2010
1	Neuroinflammatory Diseases 12/2023
1	Asthma (Bronchial Asthma) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Allergic Rhinitis 01/2022
1	Retinal Diseases 01/2022
1	Retinal Degeneration 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2020
1	Allergic Contact Dermatitis 03/2018
1	Ischemic Stroke 01/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017
1	Ischemia 01/2017
1	Infarction (Infarctions) 01/2017
1	Epilepsy (Aura) 01/2016
1	Temporal Lobe Epilepsy 01/2016
1	Central Nervous System Diseases (CNS Diseases) 08/2015
1	Macular Degeneration (Age-Related Maculopathy) 08/2015
1	Amyloid Plaque 11/2013
1	Down Syndrome (Down's Syndrome) 02/2012
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2012
1	Inflammation (Inflammations) 07/2011

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 01/2015 - 12/2010
5	Peptides (Polypeptides)IBA 08/2015 - 08/2011
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2024 - 09/2020
3	LipidsIBA 12/2023 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2011
3	Amyloid beta-PeptidesIBA 08/2015 - 01/2012
3	Amyloid (Amyloid Fibrils)IBA 08/2015 - 08/2011
3	AluminumIBA 01/2014 - 09/2013
3	Complement Factor H (Factor H)IBA 02/2012 - 07/2011
2	EndocannabinoidsIBA 01/2024 - 05/2023
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2024 - 05/2023
2	Analgesics (Analgesic Drugs)IBA 01/2024 - 05/2023
2	Opioid Analgesics (Opioids)IBA 01/2024 - 05/2023
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2024 - 05/2023
2	NF-kappa B (NF-kB)IBA 08/2014 - 12/2010
2	RNA (Ribonucleic Acid)IBA 08/2014 - 07/2011
2	Messenger RNA (mRNA)IBA 04/2013 - 02/2012
2	NucleotidesIBA 04/2013 - 07/2011
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2011 - 12/2010
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2023
1	Freund's AdjuvantIBA 05/2023
1	Poly I-CIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	AllergensIBA 01/2022
1	Retinal Pigments (Pigments, Visual)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2018
1	SaltsIBA 01/2017
1	SodiumIBA 01/2017
1	EstersIBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	LectinsIBA 04/2013
1	Immunoglobulins (Immunoglobulin)IBA 04/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012
1	Retinaldehyde (Retinal)IBA 08/2011

Therapy/Procedure

2	Therapeutics 01/2016 - 07/2012
1	Analgesia 05/2023